Skip to main content
Signal8

Lee David K

SEC insider (Form 3/4/5 filer). CIK 0002002238. Director at iTeos Therapeutics, Inc. (ITOS). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 29, 2025. Located in WATERTOWN, MA.

Companies Lee David K has filed insider reports for

  • iTeos Therapeutics, Inc. (ITOS): Director
Lee David K profile photo

Lee David K

CIK: 0002002238

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

iTeos Therapeutics, Inc. logo
ITOS

iTeos Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • iTeos Therapeutics, Inc. logo
    ITOS

    iTeos Therapeutics, Inc.

    Aug 29, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    21.1K shares-
  • iTeos Therapeutics, Inc. logo
    ITOS

    iTeos Therapeutics, Inc.

    Aug 29, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    23.6K shares-

1-2 of 2